Below are the most recent publications written about "Lymphoma" by people in Profiles.
-
Silverman RF, Abramson DH, Canestraro J, Grommes C, Francis JH. Vitreoretinal lymphoma: the importance of cerebral spinal fluid evaluation at initial diagnosis. Br J Ophthalmol. 2025 Mar 20; 109(4):504-509.
-
Valcarcel B, Savage KJ, Link BK, Leonard JP, Kelly KM, Thanarajasingam G, Cerhan JR, Pro B, Gordon LI, Thompson CA, Smith SM, Morton LM. Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda. JCO Oncol Pract. 2025 Jun; 21(6):801-812.
-
Calbert ML, Chandramouly G, Adams CM, Saez-Ayala M, Kent T, Tyagi M, Ayyadevara VSSA, Wang Y, Krais JJ, Gordon J, Atkins J, Toma MM, Betzi S, Boghossian AS, Rees MG, Ronan MM, Roth JA, Goldman AR, Gorman N, Mitra R, Childers WE, Gra?a X, Skorski T, Johnson N, Hurtz C, Morelli X, Eischen CM, Pomerantz RT. 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Mol Cancer Ther. 2024 May 02; 23(5):683-699.
-
Tekumalla S, Xu D, Awh K, Philp N, Milman T, Garg S. DIAGNOSTIC YIELD OF IN VITRO VITREOUS BIOPSY FOR INTRAOCULAR LYMPHOMA AT VARIABLE VITREOUS CUTTER SPEEDS USING 25-GAUGE VITRECTOMY. Retina. 2023 06 01; 43(6):1005-1009.
-
Wong CI, Vannatta K, Gilleland Marchak J, Quade EV, Rodgers IM, Reid CM, Dandoy CE, Billett AL, Miller TP, Vaughn S, Daraiseh NM, Liu S, Carle AC, Walsh KE. Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment. Cancer. 2023 04 01; 129(7):1064-1074.
-
Shelukar S, Fernandez C, Bas Z, Komarnicky L, Lally SE, Shields CL, Binder A, Porcu P, Alpdogan O, Martinez-Outschoorn U, Shi W. High local control and low ocular toxicity using ultra-low-dose "boom-boom" radiotherapy for indolent orbital lymphoma. Chin Clin Oncol. 2022 Dec; 11(6):44.
-
Luvisi J, Brown S, Magrath GN. Response of Bacillary Layer Detachment after Chemotherapy for Choroidal Lymphoma. Ophthalmol Retina. 2022 12; 6(12):1230.
-
Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d'Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022 09 15; 140(11):1229-1253.
-
Kalafatis NE, Agrawal KU, Ehya H, Shields CL. Cytology-Proven Primary Vitreoretinal Lymphoma in a Patient With Paraneoplastic Cloudy Vitelliform Submaculopathy. JAMA Ophthalmol. 2022 07 01; 140(7):744-745.
-
Dalvin LA, Pulido JS, Shields CL, Marchese A, Miserocchi E, Frenkel S, Pe'er J. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration. Eye (Lond). 2023 01; 37(1):54-61.